Cargando…
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Ewing sarcoma is an aggressive primary pediatric bone tumor, often diagnosed in adolescents and young adults. A pathognomonic reciprocal chromosomal translocation results in a fusion gene coding for a protein which derives its N-terminus from a FUS/EWS/TAF15 (FET) protein family member, commonly EWS...
Autores principales: | Theisen, Emily R., Pishas, Kathleen I., Saund, Ranajeet S., Lessnick, Stephen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951237/ https://www.ncbi.nlm.nih.gov/pubmed/26848860 http://dx.doi.org/10.18632/oncotarget.7124 |
Ejemplares similares
-
Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma
por: Johnson, Kirsten M., et al.
Publicado: (2017) -
Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
por: Patel, Priyal O., et al.
Publicado: (2019) -
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
por: Pishas, Kathleen I., et al.
Publicado: (2018) -
EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Cidre-Aranaz, Florencia, et al.
Publicado: (2015) -
EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma
por: Showpnil, Iftekhar A, et al.
Publicado: (2022)